Suppr超能文献

非小细胞肺癌患者胸腔灌洗液中端粒酶活性的研究及其临床意义。

Study of telomerase activity in pleural lavage fluid specimens in patients with non-small-cell lung cancer and its clinical significance.

机构信息

Department of Cardiothoracic Surgery, 1st Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, PR China.

出版信息

Eur J Cardiothorac Surg. 2009 Sep;36(3):460-4. doi: 10.1016/j.ejcts.2009.03.057. Epub 2009 Jun 6.

Abstract

OBJECTIVE

To detect telomerase activity in pleural lavage fluid specimens in patients with non-small-cell lung cancer (NSCLC) and to evaluate its clinical value.

METHODS

From July 2005 to May 2007, 167 pleural lavage fluid specimens were obtained from 135 patients with NSCLC and 32 patients with benign lung tumour during operation. Telomeric repeated amplification protocol (TRAP)-enzyme-linked immunosorbent assay (ELISA) was performed to measure the telomerase activity in these specimens. Pleural lavage cytology (PLC) analysis of the pleural lavage fluid specimens was used for comparison. All the above specimens were examined within 3h.

RESULTS

The positive rate of telomerase activity and PLC in pleural lavage fluid from patients with NSCLC was 25.2% (34/135) and 8.1% (11/135), respectively, with a significant difference (P<0.05). Telomerase activity was detected in all 11 specimens with positive cytological examination. Telomerase activity was negative in all 32 patients with benign lung tumour. There was a significant relationship between telomerase activity and pleural extension, T level, N level as well as the clinical TNM (tumour, node, metastasis) stage of lung cancer. A significant association was found between positive telomerase activity and overall survival rate, even stage I survival rate. Multivariate Cox regression analysis demonstrated that telomerase activity, as well as PLC and the TNM stage were independent predictors of prognosis.

CONCLUSION

Telomerase activity is a useful adjunct for cytological method in the diagnosis of pleural micro-metastasis and was related to prognosis in a patient with NSCLC.

摘要

目的

检测非小细胞肺癌(NSCLC)患者胸腔灌洗液标本中的端粒酶活性,并评估其临床价值。

方法

2005 年 7 月至 2007 年 5 月,在手术中对 135 例 NSCLC 患者和 32 例良性肺肿瘤患者的 167 例胸腔灌洗液标本进行了端粒重复扩增协议(TRAP)-酶联免疫吸附测定(ELISA),以测量这些标本中的端粒酶活性。对胸腔灌洗液标本进行胸腔灌洗细胞学(PLC)分析进行比较。所有上述标本均在 3 小时内检查完毕。

结果

NSCLC 患者胸腔灌洗液中端粒酶活性和 PLC 的阳性率分别为 25.2%(34/135)和 8.1%(11/135),差异有统计学意义(P<0.05)。细胞学检查阳性的 11 例标本均检测到端粒酶活性。32 例良性肺肿瘤患者的端粒酶活性均为阴性。端粒酶活性与胸腔扩展、T 级、N 级以及肺癌的临床 TNM(肿瘤、淋巴结、转移)分期之间存在显著关系。端粒酶活性与总生存率,甚至 I 期生存率呈正相关。多变量 Cox 回归分析表明,端粒酶活性以及 PLC 和 TNM 分期是预后的独立预测因子。

结论

端粒酶活性是一种有用的细胞学方法辅助诊断胸腔微转移的方法,与 NSCLC 患者的预后有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验